| | | | |
CUSIP No. 00091E109 | | | | Page 4 of 6 Pages |
ITEM 1 (a). | NAME OF ISSUER |
Absci Corporation (the “Issuer”)
ITEM 1 (b). | ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES |
18105 SE Mill Plain Blvd
Vancouver, WA 98683
ITEM 2 (a). | NAME OF PERSONS FILING |
This joint statement on Schedule 13G is being filed by Phoenix General Partner II LLC, a Delaware limited liability company (the “General Partner”), and Phoenix Venture Partners II, LP, a Delaware limited partnership (the “Fund” and, together with the General Partner, the “Reporting Persons”).
The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to this Schedule 13G, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
ITEM 2 (b). | ADDRESS OF PRINCIPAL BUSINESS OFFICE |
The business address of each of the Reporting Persons is 1700 El Camino Real, Suite 355, San Mateo, CA 94402.
The Fund is a Delaware limited partnership; and the General Partner is a Delaware limited liability company.
ITEM 2 (d). | TITLE OF CLASS OF SECURITIES |
Common stock, par value $0.0001 per share (the “Common Stock”).
00091E109
| (a) | Amount beneficially owned by each Reporting Person: 14,379,522 shares of Common Stock. |
| (b) | Percent of class beneficially owned by each Reporting Person: 15.5%. |
| (c) | Number of shares as to which each of the Fund and the General Partner has (i) the sole power to vote or direct the vote of: 14,379,522, (ii) the shared power to vote or to direct the vote of: 0, (iii) the sole power to dispose or to direct the disposal of: 14,379,522, and (iv) the shared power to dispose or to direct the disposal of: 0. |